Company Data

Aptorum Group Limited

Ticker
APM
Current Price
$1.0951 -1.34%
Market Cap
$5.7M
Price Target
Refer to Report
Volume
34.1K
52wk Range
$0.46 - $17.49
Advanced Market Data

Overview

Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The company operates in two segments: Therapeutics and Non-Therapeutics. Its lead projects are ALS-4, SACT-1, and RPIDD. It is also engaged in providing healthcare services.

Inbox Intel from Channelchek.

Informed investors make more money. And itā€™s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy